These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11136936)

  • 21. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.
    Lees KR; Barer D; Ford GA; Hacke W; Kostulas V; Sharma AK; Odergren T;
    Stroke; 2003 Feb; 34(2):482-7. PubMed ID: 12574564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.
    Green AR; Ashwood T; Odergren T; Jackson DM
    Pharmacol Ther; 2003 Dec; 100(3):195-214. PubMed ID: 14652110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetic modelling and estimation of dosing strategy for NXY-059, a nitrone being developed for stroke.
    Jönsson S; Cheng YF; Edenius C; Lees KR; Odergren T; Karlsson MO
    Clin Pharmacokinet; 2005; 44(8):863-78. PubMed ID: 16029070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores.
    Lapchak PA; Song D; Wei J; Zivin JA
    Exp Neurol; 2004 Aug; 188(2):279-85. PubMed ID: 15246827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species.
    Marshall JW; Cross AJ; Ridley RM
    Exp Neurol; 1999 Mar; 156(1):121-9. PubMed ID: 10192783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomethiazole protects against hemineglect in a primate model of stroke.
    Marshall JW; Cross AJ; Jackson DM; Green AR; Baker HF; Ridley RM
    Brain Res Bull; 2000 May; 52(1):21-9. PubMed ID: 10779698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nitroxide antioxidant tempol is cerebroprotective against focal cerebral ischemia in spontaneously hypertensive rats.
    Leker RR; Teichner A; Lavie G; Shohami E; Lamensdorf I; Ovadia H
    Exp Neurol; 2002 Aug; 176(2):355-63. PubMed ID: 12359177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NXY-059: a neuroprotective agent in acute stroke.
    Wang CX; Shuaib A
    Int J Clin Pract; 2004 Oct; 58(10):964-9. PubMed ID: 15587776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
    Liu XF; Fawcett JR; Thorne RG; DeFor TA; Frey WH
    J Neurol Sci; 2001 Jun; 187(1-2):91-7. PubMed ID: 11440750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NXY-059: a hopeful sign in the treatment of stroke.
    Hess DC
    Stroke; 2006 Oct; 37(10):2649-50. PubMed ID: 16946156
    [No Abstract]   [Full Text] [Related]  

  • 33. NXY-059 for the treatment of acute ischemic stroke.
    Shuaib A; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Diener HC; Ashwood T; Wasiewski WW; Emeribe U;
    N Engl J Med; 2007 Aug; 357(6):562-71. PubMed ID: 17687131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NXY 059: CPI 22, NXY 059G.
    Adis International Ltd
    Drugs R D; 2003; 4(4):254-7. PubMed ID: 12848592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The free radical spin-trap alpha-PBN attenuates periinfarct depolarizations following permanent middle cerebral artery occlusion in rats without reducing infarct volume.
    Christensen T; Bruhn T; Diemer NH
    Brain Res; 2003 Nov; 990(1-2):66-76. PubMed ID: 14568331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.
    Callaway JK; Knight MJ; Watkins DJ; Beart PM; Jarrott B
    Stroke; 1999 Dec; 30(12):2704-12; discussion 2712. PubMed ID: 10583001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates.
    Furuichi Y; Maeda M; Moriguchi A; Sawamoto T; Kawamura A; Matsuoka N; Mutoh S; Yanagihara T
    J Cereb Blood Flow Metab; 2003 Oct; 23(10):1183-94. PubMed ID: 14526229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nitrone free radical scavenger NXY-059 is neuroprotective when administered after traumatic brain injury in the rat.
    Clausen F; Marklund N; Lewén A; Hillered L
    J Neurotrauma; 2008 Dec; 25(12):1449-57. PubMed ID: 19118455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death.
    Leker RR; Teichner A; Grigoriadis N; Ovadia H; Brenneman DE; Fridkin M; Giladi E; Romano J; Gozes I
    Stroke; 2002 Apr; 33(4):1085-92. PubMed ID: 11935065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.